| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| 8-oxodG | 8-oxo-7,8-dihydro-2′-deoxyguanosine |
| ACF | Aberrant crypt foci |
| AMPK | AMP-activated protein kinase |
| AOM | Azoxymethane |
| APC | Adenomatous polyposis coli |
| AR | Aldose reductase |
| ARE | Antioxidant responsive element |
| αSMA | α-smooth muscle actin |
| ATG4 | Autophagy related 4A cysteine peptidase |
| ATP | Adenosine triphosphate |
| Bcl-2 | B-cell lymphoma 2 |
| BER | Base excision repair |
| CAFs | Cancer-associated fibroblasts |
| CD | Crohn’s disease |
| COX-2 | Cyclooxygenase – 2 |
| CRC | Colorectal cancer |
| CSC | Cancer stem cells |
| dG | Deoxyguanosine |
| dGTP | Deoxyguanosine triphosphate |
| DR | Death receptor |
| DUOX | Dual oxidase |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| ER | Endoplasmic reticulum |
| ERK | Extracellular signal-regulated kinase |
| ETC | Electron transport chain |
| FAP | Fibroblast activation protein |
| FGFR4 | Fibroblast growth factor receptor 4 |
| FLIP | Flice inhibitory protein |
| GIT | Gastrointestinal tract |
| GPx | Glutathione peroxidase |
| HDAC | Histone deacetylase |
| HDACIs | Histone deacetylase inhibitors |
| HIF-1α | Hypoxia inducible factor 1 alpha subunit |
| HNE | 4-hydroxy-2-nonenal |
| IBD | Inflammatory bowel diseases |
| JAK | Janus kinases |
| JNK | c-Jun NH(2)-terminal kinase |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LCN-2 | Lipocalin-2 |
| LN | Lymphoid nodules |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MDSC | Myeloid-derived suppressor cells |
| MMP | Matrix metalloproteinase |
| MMR | Mismatch repair |
| MTHFD2 | Methylenetetrahydrofolate dehydrogenase |
| MYH | MutY homologue |
| NAC | N-acetyl-l-cysteine |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NEMO | Nuclear factor-kappa B essential modulator |
| NER | Nucleotide excision repair |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NOD/SCID | Non-obese diabetic/Severe combined immunodeficient |
| NO-NSAIDs | Nitric oxide-releasing non-steroidal anti-inflammatory drugs |
| NOS | Nitric oxide synthase |
| NOX | Nicotinamide adenine dinucleotide phosphate oxidase |
| NOXA1 | NOX Activator 1 |
| NOXO1 | NOX Organizer 1 |
| Nrf2 | Nuclear factor erythroid 2–related factor 2 |
| NRX | Nucleoredoxin |
| OGG1 | 8-oxoguanine DNA glycosylase 1 |
| PDGF | Platelet-derived growth factor |
| PDT | Photodynamic therapy |
| PG | Prostaglandin |
| PHD | Prolyl hydroxylase |
| PI3K | Phosphatidylinositol 3-kinase |
| PKC | Protein kinase C |
| PMA | Phorbol 12-myristate 13-acetate |
| PPP | Pentose phosphate pathway |
| PS | Pterostilbene |
| PTEN | Phosphatase and tensin homolog |
| PTP | Protein tyrosine phosphatase |
| PUFAs | Polyunsaturated fatty acids |
| RIP | Receptor interacting protein |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen species |
| RTK | Receptor tyrosine kinase |
| SNPs | Single-nucleotide polymorphisms |
| SOD | Superoxide dismutase |
| Sp | Specificity protein |
| STAT | Signal transducer and activator of transcription proteins |
| TAK1 | TGF-β1-TGF-β-activated kinase 1 |
| TAMs | Tumor-associated Macrophages |
| TGF-β | Transforming growth factor beta |
| TIGAR | TP53-induced glycolysis and apoptosis regulator |
| TME | Tumor microenvironment |
| TRAIL | TNF-related apoptosis-inducing ligand |
| Tregs | Regulatory T cells |
| UC | Ulcerative colitis |
| uPA | Urokinase-type plasminogen activator |
| VEGF | Vascular endothelial growth factor |
| VPS34 | Vacuolar protein sorting 34 |
| Wnt | Wingless-related integration site |
| XIAP | X-linked inhibitor of apoptosis protein |
| ZEB | Zinc finger-E-box-binding |